(2-(Propoxymethyl)phenyl)methanamine is primarily used in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of various bioactive compounds, particularly in the synthesis of drugs targeting neurological and psychiatric disorders. Its structure allows for modifications that can lead to the creation of molecules with potential therapeutic effects, such as antidepressants or anxiolytics. Additionally, it may be utilized in the preparation of ligands for receptor studies, aiding in the understanding of biochemical pathways and drug-receptor interactions. Its applications are largely confined to laboratory settings, where it contributes to the advancement of medicinal chemistry and drug discovery.